Join
Live feed
·
PRReleasevia Quantisnow
Johnson & Johnson logo
S&P Global Inc. logo
Sarepta Therapeutics Inc. logo
+1

Sarepta Therapeutics Set to Join S&P MidCap 400

ByQuantisnow·Wall Street's wire, on your screen.